But medical practice leaders and IT managers in the United States face many challenges because of different state privacy laws that go beyond the federal HIPAA rules.
It is very important for healthcare groups to know these laws well so they can use AI tools safely, legally, and keep patient trust.
This article explains how state privacy rules work with HIPAA, the legal rules about AI in healthcare, and practical ways to use AI safely without risking patient privacy or breaking laws.
More healthcare providers are using AI to help with clinical choices, office jobs, and talking with patients.
AI tools often handle sensitive patient information called Protected Health Information (PHI), which HIPAA controls tightly.
HIPAA has strict rules on how PHI is used, shared, and protected by healthcare entities and their partners.
Paul Rothermel, a lawyer from Gardner Law, spoke in a May 2025 webinar about AI, HIPAA, and privacy. He said AI is not just for diagnosis and research but also helps with appointments and front-office work.
He said AI must follow rules from the start of its design and use.
Healthcare organizations must make sure AI tools handle data in ways that follow HIPAA, like removing identifying details, getting patient permission, securing waivers when needed, or using limited data sets under agreements.
If they do not follow these rules, they can face fines and damage to their reputation.
But following HIPAA alone is no longer enough because many states have their own privacy laws with different rules.
Several states made privacy laws that add to or extend HIPAA’s protections.
These laws often cover health data that HIPAA does not or add extra rules for groups not fully covered by HIPAA.
Here are some important examples that affect AI in healthcare:
Each state’s law adds different rules for healthcare groups, especially if they handle data across states.
These laws may overlap or conflict, adding more duties beyond HIPAA.
Healthcare groups must study the law carefully for each AI project, focusing on where data comes from, how it’s used, and who controls it.
Using AI in healthcare means dealing with private data and following many state and federal rules. Organizations should:
The Food and Drug Administration (FDA) oversees some AI software listed as medical devices. They require approval before such software can be used.
Regulations also cover rules for paying providers, which affect how AI is adopted.
Rules change quickly, and new laws appear that impact AI.
Healthcare leaders must stay informed through lawyers, industry groups, and vendors who focus on following the law.
Ignoring these rules can cause legal and operational problems.
AI phone systems and answering services are used by many medical offices for appointments, patient questions, and billing.
Companies like Simbo AI create these tools while following healthcare privacy rules.
Automation helps reduce work for staff, letting them focus on patients.
Still, these AI tools must meet HIPAA and state privacy laws by:
Adding AI automation needs IT managers and administrators to check vendor compliance, control data access, and keep systems updated.
Good management reduces chances of accidental patient data leaks.
Strong teamwork between healthcare providers and AI vendors can ensure these tools work legally and smoothly.
For healthcare leaders in the U.S., growing privacy laws mean they must be careful and clear:
State privacy laws make rules more complex but help protect patients and guide AI use responsibly.
For example:
Each state has different rules and timelines, so healthcare groups need to make AI plans that fit their situations.
Groups working across several states face extra challenges and need broad and flexible plans.
In the future, AI will play bigger roles in clinical and office areas of healthcare.
Regulators will keep updating rules to protect privacy and patient safety without stopping new AI uses.
Success will depend on staying informed, working well with AI vendors, and adding AI governance to daily work.
By balancing AI benefits with legal compliance, healthcare leaders can improve care, lower administrative work, and keep patient data safe.
Handling state privacy laws beyond HIPAA means healthcare leaders and IT managers need to understand laws and best practices for AI use.
Organizations must build rules to keep AI clear, responsible, and secure, whether for diagnosis tools or front-office automation like those by Simbo AI.
Good management helps AI fit better in healthcare and keeps patient trust as the system changes in the United States.
AI technologies are increasingly used in diagnostics, treatment planning, clinical research, administrative support, and automated decision-making. They help interpret large datasets and improve operational efficiency but raise privacy, security, and compliance concerns under HIPAA and other laws.
HIPAA strictly regulates the use and disclosure of protected health information (PHI) by covered entities and business associates. Compliance includes deidentifying data, obtaining patient authorization, securing IRB or privacy board waivers, or using limited data sets with data use agreements to avoid violations.
Non-compliance can result in HIPAA violations and enforcement actions, including fines and legal repercussions. Improper disclosure of PHI through AI tools, especially generative AI, can compromise patient privacy and organizational reputation.
Early compliance planning ensures that organizations identify whether they handle PHI and their status as covered entities or business associates, thus guiding lawful AI development and use. It prevents legal risks and ensures AI tools meet regulatory standards.
State laws like California’s CCPA and Washington’s My Health My Data Act add complexity with different scopes, exemptions, and overlaps. These laws may cover non-PHI health data or entities outside HIPAA, requiring tailored legal analysis for each AI project.
Colorado’s AI Act introduces requirements for high-risk AI systems, including documenting training data, bias mitigation, transparency, and impact assessments. Although it exempts some HIPAA- and FDA-regulated activities, it signals increasing regulatory scrutiny for AI in healthcare.
Organizations should implement strong AI governance, perform vendor diligence, embed AI-specific privacy protections in contracts, and develop internal policies and training. Transparency in AI applications and alignment with FDA regulations are also critical.
AI should support rather than replace healthcare providers’ decisions, maintaining accountability and safety. Transparent AI use ensures trust, compliance with regulations, and avoids over-reliance on automated decisions without human oversight.
BAAs are essential contracts that define responsibilities regarding PHI handling between covered entities and AI vendors or developers. Embedding AI-specific protections in BAAs helps manage compliance risks associated with AI applications.
Medtech innovators must evolve compliance strategies alongside AI technologies to ensure legal and regulatory alignment. They should focus on privacy, security, transparency, and governance to foster innovation while minimizing regulatory and reputational risks.